Protein modifications regulate the role of 14-3-3γ adaptor protein in cAMP-induced steroidogenesis in MA-10 leydig cells

Journal of Biological Chemistry

Volumn 289, Issue 38, 2014, Pages 26542-26553

  Aghazadeh, Yasaman ^a   Ye, Xiaoying ^b   Blonder, Josip ^b   Papadopoulos, Vassilios ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; DIMERIZATION; PHOSPHORYLATION; STARS;

ACID MODIFICATION; ADAPTOR PROTEINS; HOMODIMERIZATION; LEYDIG CELLS; PROTEIN MODIFICATIONS; STEROIDOGENIC ACUTE REGULATORY PROTEINS;

PROTEINS;

CHOLESTEROL; PROTEIN 14 3 3; PROTEIN 14 3 3GAMMA; STEROIDOGENIC ACUTE REGULATORY PROTEIN; UNCLASSIFIED DRUG; CYCLIC AMP; PHOSPHOPROTEIN; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIMERIZATION; LEYDIG CELL; LIPID STORAGE; METABOLIC REGULATION; MOUSE; NONHUMAN; PROTEIN ACETYLATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; STEROIDOGENESIS; ACETYLATION; AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; BIOSYNTHESIS; MALE; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING; TUMOR CELL LINE;

14-3-3 PROTEINS; ACETYLATION; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL LINE, TUMOR; CHOLESTEROL; CYCLIC AMP; LEYDIG CELLS; MALE; MICE; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84907202520     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.569079     Document Type: Article

References (49)

1. Aitken, A., Baxter, H., Dubois, T., Clokie, S., Mackie, S., Mitchell, K., Peden, A., and Zemlickova, E. (2002) Specificity of 14-3-3 isoform dimer interactions and phosphorylation. Biochem. Soc. Trans. 30, 351-360
2. Aitken, A. (2002) Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants. Plant Mol. Biol. 50, 993-1010
3. Zhou, Y., Reddy, S., Murrey, H., Fei, H., and Levitan, I. B. (2003) Mono-meric 14-3-3 protein is sufficient to modulate the activity of the Drosoph-ila slowpoke calcium-dependent potassium channel. J. Biol. Chem. 278, 10073-10080
4. Mackintosh, C. (2004) Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem. J. 381, 329-342
5. Liu, D., Bienkowska, J., Petosa, C, Collier, R. J., Fu, H., and Liddington, R. (1995) Crystal structure of the f isoform of the 14-3-3 protein. Nature 376, 191-194
6. Xiao, B., Jones, D., Madrazo, J., Soneji, Y., Aitken, A., and Gamblin, S. (1996) Crystallization of a 14-3-3 protein. Acta Crystallogr. D Biol. Crystallogr. 52, 203-206
7. Marais, R., and Marshall, C. (1995) 14-3-3 proteins: structure resolved, functions less clear. Structure 3, 751-753
8. Rosenquist, M., Sehnke, P., Ferl, R. J., Sommarin, M., and Larsson, C. (2000) Evolution of the 14-3-3 protein family: does the large number of isoforms in multicellular organisms reflect functional specificity? J. Mol. Evol. 51, 446-458
9. Steinacker, P., Schwarz, P., Reim, K., Brechlin, P., Jahn, O., Kratzin, H., Aitken, A., Wiltfang, J., Aguzzi, A., Bahn, E., Baxter, H. C, Brose, N., and Otto, M. (2005) Unchanged survival rates of 14-3-37 knockout mice after inoculation with pathological prion protein. Mol. Cell. Biol. 25, 1339-1346
10. Benzinger, A., Popowicz, G. M., Joy, J. K., Majumdar, S., Holak, T. A., and Hermeking, H. (2005) The crystal structure of the non-liganded 14-3-3(7 protein: insights into determinants of isoform specific ligand binding and dimerization. CellRes. 15, 219-227
11. Jagemann, L. R., Pérez-Rivas, L. G., Ruiz, E. J., Ranea, J. A., Sánchez-Jimé-nez, F., Nebreda, A. R., Alba, E., and Lozano, J. (2008) The functional interaction of 14-3-3 proteins with the ERK1/2 scaffold KSR1 occurs in an isoform-specific manner. J. Biol. Chem. 283, 17450-17462
12. Pozuelo Rubio, M., Geraghty, K. M., Wong, B. H., Wood, N. T., Campbell, D. G., Morrice, N., and Mackintosh, C. (2004) 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem. J. 379, 395-408
13. Chaudhri, M., Scarabel, M., and Aitken, A. (2003) Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. Biochem. Biophys. Res. Commun. 300, 679-685
14. Liu, T. A., Jan, Y. J., Ko, B. S., Liang, S. M., Chen, S. C, Wang, J., Hsu, C, Wu, Y. M., and Liou, J. Y. (2013) 14-3-3e overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma. PLoS One 8, e57968
15. Jin, Y., Dai, M. S., Lu, S. Z., Xu, Y., Luo, Z., Zhao, Y., and Lu, H. (2006) 14-3-37 binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBOJ. 25, 1207-1218
16. Liang, X., Butterworth, M. B., Peters, K. W., Walker, W. H., and Frizzell, R. A. (2008) An obligatory heterodimer of 14-3-3/3 and 14-3-3e is required for aldosterone regulation of the epithelial sodium channel. J. Biol. Chem. 283, 27418-27425
17. Chen, Y. C, Chu, L. Y., Yang, S. F., Chen, H. L., Yet, S. F., and Wu, K. K. (2013) Prostacyclin and PPARa agonists control vascular smooth muscle cell apoptosis and phenotypic switch through distinct 14-3-3 isoforms. PLoS One 8, e69702
18. Skoulakis, E. M., and Davis, R. L. (1998) 14-3-3 proteins in neuronal development and function. Mol. Neurobiol. 16, 269-284
19. Cheah, P. S., Ramshaw, H. S., Thomas, P. Q., Toyo-Oka, K., Xu, X., Martin, S., Coyle, P., Guthridge, M. A., Stomski, F., van den Buuse, M., Wynshaw-Boris, A., Lopez, A. F., and Schwarz, Q. P. (2012) Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3f deficiency. Mol. Psychiatry 17, 451-466
20. Aitken, A. (2011) Post-translational modification of 14-3-3 isoforms and regulation of cellular function. Semin. Cell Dev. Biol. 22, 673-680
21. Han, D., Ye, G., Liu, T., Chen, C, Yang, X., Wan, B., Pan, Y., and Yu, L. (2010) Functional identification of a novel 14-3-3e splicing variant suggests dimerization is not necessary for 14-3-3e to inhibit UV-induced apoptosis. Biochem. Biophys. Res. Commun. 396, 401-406
22. Sluchanko, N. N., and Gusev, N. B. (2012) Oligomeric structure of 14-3-3 protein: what do we know about monomers? FEBS Lett. 586, 4249-4256
23. Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H, Gamblin, S. J., Smerdon, S. J., and Cantley, L. C. (1997) The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91, 961-971
24. Rittinger, K., Budman, J., Xu, J., Volinia, S., Cantley, L. C, Smerdon, S. J., Gamblin, S. J., and Yaffe, M. B. (1999) Structural analysis of 14-3-3 phos-phopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol. Cell4, 153-166
25. Ganguly, S., Weller, J. L., Ho, A., Chemineau, P., Malpaux, B., and Klein, D. C. (2005) Melatonin synthesis: 14-3-3-dependent activation and inhibition of arylalkylamine N-acetyltransferase mediated by phosphoserine-205. Proc. Natl. Acad. Sci. U.S.A. 102, 1222-1227
26. Aghazadeh, Y., Rone, M. B., Blonder, J., Ye, X., Veenstra, T. D., Hales, D. B., Culty, M., and Papadopoulos, V. (2012) Hormone-induced 14-3-37 adaptor protein regulates steroidogenic acute regulatory protein activity and steroid biosynthesis in MA-10 Leydig cells. J. Biol. Chem. 287, 15380-15394
27. Liu, J., Rone, M. B., and Papadopoulos, V. (2006) Protein-protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J. Biol. Chem. 281, 38879-38893
28. Papadopoulos, V., Liu, J., and Culty, M. (2007) Is there a mitochondrial signaling complex facilitating cholesterol import? Mol. Cell. Endocrinol. 265-266, 59-64
29. Arakane, F., King, S. R., Du, Y., Kallen, C. B., Walsh, L. P., Watari, H, Stocco, D. M., and Strauss, J. F., 3rd (1997) Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity. J. Biol. Chem. 272, 32656-32662
30. Manna, P. R., and Stocco, D. M. (2005) Regulation of the steroidogenic acute regulatory protein expression: functional and physiological consequences. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5, 93-108
31. Shen, Y. H., Godlewski, J., Bronisz, A., Zhu, J., Comb, M. J., Avruch, J., and Tzivion, G. (2003) Significance of 14-3-3 self-dimerization for phosphor-ylation-dependent target binding. Mol. Biol. Cell 14, 4721-4733
32. Hamaguchi, A., Suzuki, E., Murayama, K., Fujimura, T., Hikita, T., Iwabu-chi, K., Handa, K., Withers, D. A., Masters, S. C, Fu, H, and Hakomori, S. (2003) Sphingosine-dependent protein kinase-1, directed to 14-3-3, is identified as the kinase domain of protein kinase CS. J. Biol. Chem. 278, 41557-41565
33. Tsuruta, F., Sunayama, J., Mori, Y., Hattori, S., Shimizu, S., Tsujimoto, Y., Yoshioka, K., Masuyama, N., and Gotoh, Y. (2004) JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBOJ. 23, 1889-1899
34. Choudhary, C, Kumar, C, Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C, Olsen, J. V., and Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840
35. Uhart, M., and Bustos, D. M. (2013) Human 14-3-3 paralogs differences uncovered by cross-talk of phosphorylation and lysine acetylation. PLoS One 8, e55703
36. Rone, M. B., Liu, J., Blonder, J., Ye, X., Veenstra, T. D., Young, J. C, and Papadopoulos, V. (2009) Targeting and insertion of the cholesterol-binding translocator protein into the outer mitochondrial membrane. Biochemistry 48, 6909-6920
37. Kramer, B., Rarey, M., and Lengauer, T. (1997) CASP2 experiences with docking flexible ligands using FlexX. Proteins Suppl. 1, 221-225
38. Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., and Dowdy, S. F. (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med. 4, 1449-1452
39. Suchanek, M., Radzikowska, A., and Thiele, C. (2005) Photo-leucine and photo-methionine allow identification of protein-protein interactions in living cells. Nat. Methods 2, 261-267
40. Rone, M. B., Midzak, A. S., Issop, L., Rammouz, G., Jagannathan, S., Fan, J., Ye, X., Blonder, J., Veenstra, T., and Papadopoulos, V. (2012) Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. Mol. Endocrinol. 26, 1868-1882
41. Issop, L., Rone, M. B., and Papadopoulos, V. (2013) Organelle plasticity and interactions in cholesterol transport and steroid biosynthesis. Mol. Cell. Endocrinol. 371, 34-46
42. Arakane, F., Kallen, C. B., Watari, H, Stayrook, S. E., Lewis, M., and Strauss, J. F., 3rd (1998) Steroidogenic acute regulatory protein (StAR) acts on the outside of mitochondria to stimulate steroidogenesis. Endocr. Res. 24, 463-468
43. Johnson, C, Crowther, S., Stafford, M. J., Campbell, D. G., Toth, R., and MacKintosh, C (2010) Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem. J. 427, 69-78
44. Tzivion, G., Shen, Y. H., and Zhu, J. (2001) 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20, 6331-6338
45. Waterman, M. J., Stavridi, E. S., Waterman, J. L., and Halazonetis, T. D. (1998) ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet. 19, 175-178
46. Henriksson, M. L., Francis, M. S., Peden, A., Aili, M., Stefansson, K., Palmer, R., Aitken, A., and Hallberg, B. (2002) A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. Eur. J. Biochem. 269, 4921-4929
47. Wang, C, Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L. J., Kaufman, J. M., Legros, J. J., Lunenfeld, B., Morales, A., Morley, J. E., Schulman, C, Thompson, I. M., Weidner, W., and Wu, F. C. (2009) Investigation, treatment and monitoring of late-onset hypogonadism in males. Int. J. Androl. 32, 1-10
48. Bose, H. S., Sugawara, T., Strauss, J. F., 3rd, Miller, W. L., and International Congenital Lipoid Adrenal Hyperplasia Consortium (1996) The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N. Engl. J.Med. 335, 1870-1878
49. Alpy, F., and Tomasetto, C. (2005) Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J. Cell Sci. 118, 2791-2801